Study Sheds Light on New Pain Relief Treatments

by Sheela Philomena on  August 8, 2011 at 10:53 AM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

The study on hereditary sensory and autonomic neuropathy type II - a severe disorder that causes sensory neurons to degenerates paves way for new pain treatments. Researchers at the University of Montreal Hospital and CHU Sainte-Justine Hospital have discovered how a specific genetic mutation causes their patients' condition, which in turn has revealed more information about the mechanisms in our bodies which enable us to sense pain. Genetic mutations are mistakes in our genetic code that can either be passed from parents to their children or created when DNA is replicated.
 Study Sheds Light on New Pain Relief Treatments
Study Sheds Light on New Pain Relief Treatments

The currently untreatable disorder is called "hereditary sensory and autonomic neuropathy type II." It starts during early childhood and is characterized by a loss of perception of pain, touch and heat. Because affected individuals are unable to react to pain and protect themselves, they often develop ulcers that can become infected, leading to amputation of the affected body part. By working with their international colleagues under the direction of the University of Montreal's Dr. Guy Rouleau, the research team was able to pinpoint how the disorder is related to the patients' genetic code. "After showing that the WNK1/HSN2 protein interacts with the KIF1A gene, we were able to go back to the cohort of patients and identify mutations of the KIF1A gene," Rivičre said.

"The study results will be of immediate benefit to HSAN2 patients, as the identification of this new gene has made it possible to provide valuable genetic testing to assess the risk or the cause of the disease in individuals at risk or presenting the disease." While the genetic mutation affects very few people, the knowledge that the researchers have gained is applicable to everyone. Scientists know the different parts of our genetic code, but they don't know how every single specific gene contributes to the functioning of our bodies. When a gene does not function properly due to a mutation, the resulting disorder can provide insight into its normal role. These findings provide clues about the components underlying the transmission of pain signal from sites of injury to the central nervous system.

Researchers may be able to use their new knowledge about the KIF1A gene to develop new pain relief drugs. "Our results not only open the door to a better understanding of this disorder," Rouleau explained, "they also give us valuable information about the molecular mechanisms involved in pain perception, which is important for the development of new anti-pain drugs." A future drug might work by modulating interactions between different proteins associated with pain and KIF1A. "Further research could help us to identify other proteins that are transported by KIF1A or that interact with it, and that will help to better refine our understanding of pain mechanisms," noted Dr. Patrick Dion, who also contributed to the research.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Thoracic Outlet Syndrome Exercising Tips For Nerve Pain Relief Top 15 Natural Painkillers Pain Management for Burn Injuries Sciatica Exercises: Stretches for Pain Relief 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive